JUNS Stock Price and Chart — NASDAQ:JUNS — TradingView

Overview

About Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

‪0.00‬

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jupiter Neurosciences, Inc. stocks are traded under the ticker JUNS.

JUNS stock has risen by 37.25% compared to the previous week, the month change is a 37.25% rise, over the last year Jupiter Neurosciences, Inc. has showed a 38.50% increase.

Yes, you can track Jupiter Neurosciences, Inc. financials in yearly and quarterly reports right on TradingView.

JUNS net income for the last quarter is ‪313.12 K‬ USD, while the quarter before that showed ‪−634.10 K‬ USD of net income which accounts for 149.38% change. Track more Jupiter Neurosciences, Inc. financial stats to get the full picture.

No, JUNS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, JUNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jupiter Neurosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.